Mostly Markets
Subscribe
Stocks/Health Care/Life Sciences Tools & Services

Agilent TechnologiesA

Life Sciences Tools & Services · Santa Clara, California · In the S&P 500
Solid businessPricier than peers
$174.87−3.47%After hours: $171.27 (−2.06%)At the close, 30 Oct · Prices from CNBC, may be delayed
▲ 22.1% over 1 year
Agilent Technologies over 1 yearDaily close, $, to 30 Oct 2026
$120$140$160$180Nov2026MarMayJulSep$174.87$150NovMarJul$174.87
Source: Nasdaq daily closes
Market value$49.30B
Price to earnings34.5x
Forward P/E26.6x
Dividend yield0.58%
Year to date+28.5%
One year+22.1%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$110.24$181.48

Quality and valuation

How Agilent Technologies compares with other health care stocks. A description, not a recommendation.

Agilent Technologies and 7 life sciences tools & services peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: pricier than most

An average business among health care companies, priced above most of them.

Agilent Technologies trades at 26.6 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew faster than the sector median: +8.6% vs +7.8%
  • Keeps less of each sale (gross margin): 53.8% vs 65.3%
  • More profitable (operating margin): 22.2% vs 13.3%
  • Turns more of its sales into cash: 17.2% vs 15.9%
A trades at 26.6x forward earnings, above the sector medianForward p/e, Life Sciences Tools & Services peers
IQV19.8xDHR26.5xTMO26.6xA26.6xCRL29.1xWAT29.8xMTD34.1xILMN41.6xSector median 19.1xIQV19.8xDHR26.5xTMO26.6xA26.6xCRL29.1xWAT29.8xMTD34.1xILMN41.6xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 34.4x earnings, A is pricier than its average since Aug 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
25x30xAverage 29.1x2025202634.4x25x30xAverage 29.1x2025202634.4x
Source: Nasdaq prices; SEC filings

Financials

From Agilent Technologies's SEC filings, through the quarter ending 31 Jul 2026. Hover or tap a bar for its value.

Revenue grew 8.1% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0.0bn$0.5bn$1.0bn$1.5bnQ4 ’24Q2 ’25Q4 ’25$1.9bnQ3 ’26$0bn$1bnQ4 ’24Q2 ’25Q4 ’25$1.9bnQ3 ’26
Source: SEC filings
Growth slowed to +8.1% last quarterRevenue growth, year on year, %
0%5%10%Q4 ’24Q2 ’25Q4 ’258.1%Q3 ’260%5%10%Q4 ’24Q2 ’25Q4 ’258.1%Q3 ’26
Source: SEC filings
Operating margin was 23.6% last quarterOperating income as a share of revenue, %
0%10%20%Q4 ’24Q2 ’25Q4 ’2523.6%Q3 ’260%10%20%Q4 ’24Q2 ’25Q4 ’2523.6%Q3 ’26
Source: SEC filings
Free cash flow was $1.3 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$200m$400mQ4 ’24Q2 ’25Q4 ’25$439mQ3 ’26$0m$200m$400mQ4 ’24Q2 ’25Q4 ’25$439mQ3 ’26
Source: SEC filings
Last 12 monthsASector median
Revenue growth+8.6%+7.8%
Gross margin53.8%65.3%
Operating margin22.2%13.3%
Free cash flow margin17.2%15.9%
Price to earnings34.5x30.2x

Stories on Agilent Technologies

We haven't written about Agilent Technologies yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Life Sciences Tools & Services, by market value.

CompanyPriceTodayYTDValue
TMOThermo Fisher Scientific$697.00−1.72%+20.3%$258B
DHRDanaher$232.23−2.00%+1.4%$163B
WATWaters$462.72−3.61%+21.8%$45.46B
IQVIQVIA$267.33−2.81%+18.6%$44.06B
ILMNIllumina$235.99−18.64%+79.9%$35.63B
MTDMettler Toledo$1,674.81−2.55%+20.1%$33.56B
CRLCharles River Laboratories$359.41−4.44%+80.2%$17.16B
TECHBio-Techne$72.66−0.07%+23.6%$11.41B